Skip to main content

Site notifications

TGA provisionally approves the Biocelect Pty Ltd (Novavax) COVID-19 vaccine, NUVAXOVID, for use in individuals aged 12-17 years

Published

Related content

Help us improve the Therapeutic Goods Administration site